Dapagliflozin QD and exenatide QW dual therapy: a 24-week...

  • Main
  • 2016 / 08
  • Dapagliflozin QD and exenatide QW dual therapy: a 24-week...

Dapagliflozin QD and exenatide QW dual therapy: a 24-week randomized, placebo-controlled, phase 2 study examining effects on bodyweight and prediabetes in obese nondiabetic adults

Lundkvist, Per, David Sjöström, C., Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12779
Date:
August, 2016
File:
PDF, 1.19 MB
english, 2016
Conversion to is in progress
Conversion to is failed